Showing 1,664 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C transmission & prevention

HCV sexual transmission: HIV negative may be at risk, more awareness and testing needed

Editor's pick
HIVandHepatitis.com
16 October 2014
Hepatitis & HIV

Coffee, Even Decaf, May Promote Liver Health

Editor's pick
AIDSMeds
16 October 2014
New & experimental hepatitis C treatment

IDWeek 2014: AbbVie 3D HCV Regimen Well-tolerated in PEARL Trials

Editor's pick
HIVandHepatitis.com
16 October 2014
Hepatitis C treatment

Unique 'pay if you clear' proposal for new hepatitis drug

Editor's pick
BBC
15 October 2014
Hepatitis C transmission & prevention

Egypt: Poor infection control to blame for hepatitis C epidemic

Editor's pick
Nature Middle East
15 October 2014
New & experimental hepatitis C treatment

Fair Pricing Coalition Urges a Uniform Price for Curative Hepatitis C Treatment

Editor's pick
Fair Pricing Coalition
15 October 2014
Pharmaceutical industry

If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?

Editor's pick
Wall Street Journal
15 October 2014
Hepatitis C treatment

As Hepatitis Pill Harvoni Joins Sovaldi, States Erect Medicaid Hurdles

Editor's pick
Forbes
10 October 2014
New & experimental hepatitis C treatment

U.S. Food and Drug Administration Approves Gilead’s Harvoni® (Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C

Editor's pick
Gilead press release
10 October 2014
Hepatitis C treatment

Thousands of Hep C patients in Alexandria wait in long lines to receive Sovaldi

Editor's pick
Egypt Independent
10 October 2014
Hepatitis C treatment

Sovaldi ‘unaffordable’ says NHS documents

Editor's pick
Pharmafile
8 October 2014
New & experimental hepatitis C treatment

In a surprise move, Bristol-Myers drops U.S. approval plans for hep C drug

Editor's pick
Fierce Biotech
7 October 2014
Hepatitis C treatment

CVS: One In 12 Hepatitis C Patients Not Adhering To $1,000/Day Pill

Editor's pick
Forbes
7 October 2014
Hepatitis C treatment

Most Spanish patients coinfected with HIV/HCV called difficult to cure

Editor's pick
Healio
7 October 2014
Hepatitis C treatment

New Hepatitis C Treatment Too Pricey For All Patients

Editor's pick
KJZZ Radio
7 October 2014
Hepatitis C transmission & prevention

Investigating an outbreak of hepatitis C virus among MSM without HIV

Editor's pick
CATIE
1 October 2014
Pharmaceutical industry

J&J makes a splash in hep C with a $1.75B deal for Alios

Editor's pick
Fierce Biotech
1 October 2014
Hepatitis C treatment

France uses tax to put pressure on hepatitis C drug prices

Editor's pick
Reuters
1 October 2014
New & experimental hepatitis C treatment

After Patient's Death, Study Shows HCV Drug Cardiotoxic in 14 of 34 Treated Patients

Editor's pick
Medscape (requires registration)
29 September 2014
New & experimental hepatitis C treatment

Patent landscape for hepatitis issued by WHO

Editor's pick
Intellectual Property Watch
29 September 2014
New & experimental hepatitis C treatment

European CHMP Adopts Positive Opinion for Gilead’s Harvoni® (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection in Adults

Editor's pick
Gilead press release
29 September 2014
Hepatitis C treatment

Why Gilead’s Recent Deal with Generic Producers for its Hepatitis C Drugs (Sofosbuvir and Ledipasvir) is a Sham

Editor's pick
ITPC
25 September 2014
Hepatitis C treatment

NICE consults on draft guidance on the drug simeprevir (Olysio) for treating hepatitis C

Editor's pick
NICE
25 September 2014
Hepatitis C treatment

As Gilead Mulls Price of Next Hepatitis C Drug, Top Activist Refutes "Bogus" Math

Editor's pick
TheBody.com
24 September 2014